Compare CADL & STRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CADL | STRS |
|---|---|---|
| Founded | 1999 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 357.4M | 241.5M |
| IPO Year | 2021 | 1994 |
| Metric | CADL | STRS |
|---|---|---|
| Price | $5.10 | $31.57 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $19.00 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 13.5K |
| Earning Date | 05-12-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 58.62 | ★ 512.50 |
| EPS | N/A | ★ 1.47 |
| Revenue | $125,000.00 | ★ $29,914,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $21.11 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.34 | $15.28 |
| 52 Week High | $7.24 | $32.93 |
| Indicator | CADL | STRS |
|---|---|---|
| Relative Strength Index (RSI) | 52.99 | 57.96 |
| Support Level | $4.57 | $28.22 |
| Resistance Level | $5.25 | $32.93 |
| Average True Range (ATR) | 0.23 | 1.11 |
| MACD | 0.03 | 0.05 |
| Stochastic Oscillator | 84.97 | 78.78 |
Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
Stratus Properties Inc is a diversified real estate company operating in the United States. It is engaged in the acquisition, entitlement, development, management, operation and sale of commercial, multi- and single-family residential real estate properties, located in the Austin Texas area and other select markets in Texas. It operates its business through two segments namely, Real Estate Operations and Leasing Operations. Real Estate Operations segment encompasses activities associated with entitlement, development, and sale of real estate. Leasing Operations segment involves leasing of commercial space at retail and mixed-use properties and residences in multi-family properties that company developed. Majority of revenue is from Real Estate Operations.